Lactobacillus Reuteri for Bone Health

Research suggests that Lactobacillus reuteri may support bone health through several interconnected pathways, particularly by modulating the gut microbiome, reinforcing intestinal barrier integrity, and regulating immune signaling that influences bone remodeling. The majority of available evidence comes from preclinical animal studies — primarily in mice and rats — with no human clinical trials in this collection, and these studies generally show that L. reuteri can help prevent bone loss in contexts including antibiotic-induced gut dysbiosis, estrogen deficiency, Type 1 diabetes, and glucocorticoid use, with proposed mechanisms involving suppression of bone-resorbing osteoclasts, preservation of the Wnt10b signaling pathway, and lymphocyte-mediated promotion of bone-building osteoblasts. Some findings are mixed or context-dependent — for instance, one study found bone benefits in female mice only when inflammation was already present, and a postbiotic study found that preparations from other strains outperformed L. reuteri-derived compounds — and at least two studies included in this collection did not directly investigate L. reuteri or were irrelevant to bone health. The overall picture is promising but preliminary, and translation of these animal findings to human outcomes remains an important and unresolved question requiring well-designed clinical trials.